Levofloxacin/rituximab | springermedizin.de

Springer Medizin

nach oben

Reactions Weekly

Erschienen in:

01.10.2016 | Case report

Levofloxacin/rituximab

Acute generalised exanthematous pustulosis (first report with rituximab): case report

Erschienen in: Reactions Weekly | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Excerpt

Author Information

An event is serious (FDA MedWatch definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* requires intervention to prevent permanent impairment or damage

First published case report …

Anzeige

Bazire R, et al. Severe cutaneous adverse reaction related to rituximab. Allergy 71 (Suppl. 102): 344 abstr. 734, Aug 2016. Available from: URL: http://doi.org/10.1111/all.12974 [abstract] - Spain

Titel: Levofloxacin/rituximab
Acute generalised exanthematous pustulosis (first report with rituximab): case report
Publikationsdatum: 01.10.2016
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2016
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-016-21712-3